Mirova US LLC increased its position in Xylem Inc. (NYSE:XYL - Free Report) by 4.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,000,499 shares of the industrial products company's stock after buying an additional 94,228 shares during the quarter. Xylem accounts for approximately 2.7% of Mirova US LLC's holdings, making the stock its 17th biggest holding. Mirova US LLC owned about 0.82% of Xylem worth $258,785,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in XYL. NBC Securities Inc. purchased a new position in Xylem during the 1st quarter valued at $72,000. Merit Financial Group LLC increased its position in Xylem by 13.0% during the 1st quarter. Merit Financial Group LLC now owns 2,707 shares of the industrial products company's stock valued at $323,000 after purchasing an additional 312 shares during the period. Wedmont Private Capital increased its position in Xylem by 6.1% during the 1st quarter. Wedmont Private Capital now owns 2,348 shares of the industrial products company's stock valued at $256,000 after purchasing an additional 136 shares during the period. City Holding Co. increased its position in Xylem by 8.9% during the 1st quarter. City Holding Co. now owns 2,392 shares of the industrial products company's stock valued at $286,000 after purchasing an additional 196 shares during the period. Finally, Farther Finance Advisors LLC increased its position in Xylem by 30.4% during the 1st quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock valued at $215,000 after purchasing an additional 419 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is owned by company insiders.
Xylem Stock Performance
Shares of NYSE XYL opened at $148.12 on Wednesday. The firm's 50-day moving average price is $142.63 and its 200-day moving average price is $129.90. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The company has a market cap of $36.05 billion, a PE ratio of 38.47, a PEG ratio of 2.59 and a beta of 1.13. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $151.16.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business's quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Thursday, August 28th. Xylem's dividend payout ratio is 41.56%.
Analyst Ratings Changes
XYL has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Stifel Nicolaus upped their target price on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. UBS Group upped their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Xylem in a research report on Saturday, September 27th. Finally, Barclays initiated coverage on shares of Xylem in a research report on Friday, September 19th. They issued an "overweight" rating and a $165.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $152.33.
Read Our Latest Stock Report on XYL
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.